Cell Metabolism Under Microenvironmental Low Oxygen Tension Levels in Stemness, Proliferation and Pluripotency
Journal:
Current Molecular Medicine
Volume:
15
Page:
343-359
Author(s):
M.P. De Miguel, Y. Alcaina, D. Sainz de la Maza and P. Lopez-Iglesias
Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy
Journal:
Clinical Cancer Drugs
Volume:
2
Page:
61-70
Author(s):
Kelly Lien, Michelle Rocha, Elisa Tran, Van C. Hoang, Annabelle Chow and Urban Emmenegger
Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
2187-2197
Author(s):
Xiao Liu, Andrew J. Teichtahl and Ian P. Wicks
Drug Delivery Technologies and Stem Cells for Tissue Repair and Regeneration
Journal:
Current Pharmaceutical Biotechnology
Volume:
16
Page:
646-654
Author(s):
Gorka Orive, Raquel Cobos, Janire Gorriti, Jose L. Pedraz, Mirella Meregalli and Yvan Torrente
FBP1, A Tumor Suppressor and Negative Regulator of Glycolysis, was Epigenetically Silenced in Pancreatic Cancer
Journal:
Current Signal Transduction Therapy
Volume:
9
Page:
156-163
Author(s):
Bo Zhang, Yi Qin, Si Shi, Shunrong Ji, Wenyan Xu, Jiang Liu, Jiang Long, Chen Liu, Liang Liu, Quanxing Ni, Jin Xu and Xianjun Yu
The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies
Journal:
Current Cancer Drug Targets
Volume:
15
Page:
145-157
Author(s):
Jinming Shi, Aixin Hao, Qiang Zhang and Guangchao Sui
Hedgehog Signaling and Urological Cancers
Journal:
Current Drug Targets
Volume:
16
Page:
258-271
Author(s):
Katsumi Shigemura and Masato Fujisawa
Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
15
Page:
307-313
Author(s):
Sara Pilotto, Stefania Kinspergher, Umberto Peretti, Anna Calio, Luisa Carbognin, Roberto Ferrara, Matteo Brunelli, Marco Chilosi, Giampaolo Tortora and Emilio Bria
Oncotargets in Different Renal Cancer Subtypes
Journal:
Current Drug Targets
Volume:
16
Page:
125-135
Author(s):
Holger Moch, Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng and Axel Mischo
Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview
Journal:
Current Drug Targets
Volume:
16
Page:
96-102
Author(s):
Rodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, Liang Cheng, Holger Moch and Marina Scarpelli